Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?
Cristiane Decat Bergerot(MedSIR (Spain)), Maryam B. Lustberg(Yale Cancer Center), Stacey Tinianov(Advocates for Youth), Errol J. Philip(University of California, San Francisco), Paulo Gustavo Bergerot(Hospital Estadual Centra), Namrah Siddiq(Yale Cancer Center)
Cited by 83
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Triple-negative breast cancer: promising prognostic biomarkers currently in development
|Expert Review of Anticancer Therapy|2020|236